We create precision medicines that free normal immunity to defeat cancer using proprietary platforms that uncover novel immuno-oncology mechanisms.
Why hasn’t cancer immunotherapy reached its full potential?
There is untapped biology to discover how to simply free the immune system to work normally against cancer.
We are freeing the potential for Normunity.
We are a fusion of inspired minds
making the next advance in I-O drug discovery.
Our innovation engine is built on an immersive academic-biotech partnership between the Lieping Chen lab at the Yale School of Medicine and Normunity, across two areas:
Platforms
Platforms from the ongoing partnership with the Chen lab reveal previously unknown insights and mechanisms for how normal immune response is disrupted in cancer.
Drug Discovery
Drug discovery at Normunity targets these novel mechanisms with a new class of cancer immunotherapies, called immune normalizers, that free the most powerful force against cancer: the normal immune system.
Drug Discovery
Our sights are set on new medicines to
help More patients
because we know that not enough cancer patients respond to today’s immunotherapies.
Your next career move is in plain sight.
Activate your hidden potential and join the Normunity team.
